Clinical Trial Update: Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating radiation therapy followed by atezolizumab in stage II or stage III non-small cell lung cancer; the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING